In this study, we report the results of the epidemiological analysis of Clostridioides difficile ribotypes (RTs) and antimicrobial susceptibility testing. Most isolates were RT027, representing 73% (84/115) of isolates. No isolates with reduced susceptibility to fidaxomicin were found; however, 38 (33.04%) isolates had reduced susceptibility to metronidazole, and 7 isolates (6.1%) had reduced susceptibility to vancomycin. These findings highlight the need for continuous surveillance of C. difficile RTs and antimicrobial susceptibility testing.
Bibliographical noteFunding Information:
This work was funded by Consejo Nacional de Ciencia y Tecnología (Grant 284042).
© Copyright 2021, Mary Ann Liebert, Inc., publishers 2021.
All Science Journal Classification (ASJC) codes
- Microbiology (medical)